Efficacy in Relapse Prevention: Psilocybin in Alcohol Use Disorder With Depressive Symptoms

Phase: PHASE3 | Sponsor: Centre Hospitalier Universitaire de Nīmes | Compound: Psilocybin

Status

recruiting

Institution

Centre Hospitalier Universitaire de Nīmes

Start date

2026-06-01

End date

2030-06-01

Registry ID

NCT07638553

View trial record

Tracked by the DMT Code Clinical Trials Observatory, an open record of DMT-related clinical research.